PEGylated recombinant EPO (Polytherics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePEGylated recombinant EPO (Polytherics)
Drug Alias NameRecombinant EPO (Polytherics)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbzena Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbzena Ltd
Active IndicationsN/A
Inactive IndicationsAnemia

Other Information

ATC CodeN/A
Related LinksN/A